Katherine A. Ortmeyer

SGLT2-mediated glucose uptake defines early metabolic reprogramming in lung adenocarcinoma

Abstract The metabolic reprogramming taking place during early lung adenocarcinoma (LUAD) progression remain poorly understood. While early-stage LUAD frequently demonstrates low 18F-2-fluorodeoxyglucose (18FDG) uptake on positron emission tomography (PET), it is unclear whether...